Summary: Myelodysplastic Syndrome (MDS) is a heterogeneous group of clonal hematopoietic malignancies characterized by progressive cytopenias, ineffective hematopoiesis, bone marrow hypercellularity and transformation to acute myeloid leukemia (AML). Objectives: Identify plasma proteins from MDS patients and from two healthy controls groups (young and elderly) by SDS-Page. Methods: Plasma from 08 healthy young, 08 healthy elderly and 08 MDS patients were used for this study. Proteins were fractionated, precipitated, used for SDS-PAGE gel analysis, stained with comassie brilliant blue, scanned and bands were analyzed. Results: It was possible to identify in both, 20% fraction and supernatant, proteins that were differentially expressed in ea...
Prospective analysis of the importance of the plasma levels of beta-2 microglobulin (B2M) in 553 pat...
Aims: This study aimed to identify potential, non-invasive biomarkers for diagnosis and monitoring o...
Aims: This study aimed to identify potential, non-invasive biomarkers for diagnosis and monitoring o...
Copyright © 2015 Pavel Majek et al. This is an open access article distributed under the Creative Co...
In recent years the plasma proteomes of several different myelodysplastic syndrome (MDS) subgroups h...
Copyright © 2014 Pavel Majek et al. This is an open access article distributed under the Creative Co...
Oxidative stress is an important factor in carcinogenesis of oncohematological diseases. However its...
Introduction: Myelodysplastic syndromes (MDS) are characterized by bone marrow failure due to distur...
Introduction: Myelodysplastic syndromes (MDS) are characterized by bone marrow failure due to distur...
Myelodysplastic syndromes (MDS) are a type of blood cancer that derive from ineffective hematopoiesi...
Contains fulltext : 57386.pdf (publisher's version ) (Closed access)Myelodysplasti...
The goal of this study was to explore the plasma proteome of myelodysplastic syndrome (MDS) patients...
Background: Multiple myeloma (MM) is a malignant tumor, which takes the second place in malignant bl...
Myelodysplastic syndromes (MDS) are clonal disorders of hematopoietic stem cells and are mostly obse...
Myelodysplastic syndromes (MDS) are a collection of pathologi-cally and cytogenetically distinct bon...
Prospective analysis of the importance of the plasma levels of beta-2 microglobulin (B2M) in 553 pat...
Aims: This study aimed to identify potential, non-invasive biomarkers for diagnosis and monitoring o...
Aims: This study aimed to identify potential, non-invasive biomarkers for diagnosis and monitoring o...
Copyright © 2015 Pavel Majek et al. This is an open access article distributed under the Creative Co...
In recent years the plasma proteomes of several different myelodysplastic syndrome (MDS) subgroups h...
Copyright © 2014 Pavel Majek et al. This is an open access article distributed under the Creative Co...
Oxidative stress is an important factor in carcinogenesis of oncohematological diseases. However its...
Introduction: Myelodysplastic syndromes (MDS) are characterized by bone marrow failure due to distur...
Introduction: Myelodysplastic syndromes (MDS) are characterized by bone marrow failure due to distur...
Myelodysplastic syndromes (MDS) are a type of blood cancer that derive from ineffective hematopoiesi...
Contains fulltext : 57386.pdf (publisher's version ) (Closed access)Myelodysplasti...
The goal of this study was to explore the plasma proteome of myelodysplastic syndrome (MDS) patients...
Background: Multiple myeloma (MM) is a malignant tumor, which takes the second place in malignant bl...
Myelodysplastic syndromes (MDS) are clonal disorders of hematopoietic stem cells and are mostly obse...
Myelodysplastic syndromes (MDS) are a collection of pathologi-cally and cytogenetically distinct bon...
Prospective analysis of the importance of the plasma levels of beta-2 microglobulin (B2M) in 553 pat...
Aims: This study aimed to identify potential, non-invasive biomarkers for diagnosis and monitoring o...
Aims: This study aimed to identify potential, non-invasive biomarkers for diagnosis and monitoring o...